Advertisement
Advertisement

‘No one explained any of it’ – Griner relives her arrest in Russian trial

By:
Reuters
Updated: Jul 27, 2022, 18:06 UTC

KHIMKI, Russia (Reuters) - U.S. basketball player Brittney Griner, on trial in Russia on drug charges, arrived in court on Wednesday to testify in a case that could see her face up to 10 years in prison.

U.S. basketball player Griner back in Russian court on drugs charges

KHIMKI, Russia (Reuters) -U.S. basketball star Brittney Griner told a Russian court on Wednesday she was not read her rights when detained at a Moscow airport in February, as she stands trial for drug charges that could see her face up to 10 years in prison.

The 31-year-old, a Women’s National Basketball Association (WNBA) star who has played in Russia during the league’s offseason, was detained at Moscow’s Sheremetyevo airport on Feb. 17 with vape cartridges containing hashish oil in her luggage.

Wearing a long-sleeved T-shirt from her WNBA team, the Phoenix Mercury, Griner testified that she was stopped at customs as she was headed to board a flight to Ekaterinburg, a city 1,400 km (870 miles) east of the Russian capital.

The two-time Olympic champion was on her way to join her Russian team, UMMC Ekaterinburg, for the playoffs after spending time at home in the United States.

Griner said officers removed vape cartridges from her luggage, opened them and sniffed their contents. She said she was asked to sign documents but had to use Google Translate to understand them.

“My rights were never read to me. No one explained any of it to me,” Griner said. “At that point, I got on my phone and I contacted my spouse, my sports agent and my club team’s translator.”

Seated in the defendant’s cage, Griner said she was provided with an interpreter at the airport who just told her: “Surname. Sign.”

“She didn’t explain the content of the paper,” Griner said. “I didn’t know exactly what I was signing.”

‘PACKING IN A RUSH’

Griner has pleaded guilty to the charges against her but has denied she intended to break Russian law.

“I do plead guilty because of the actions that have happened but again, I did not intend to smuggle or bring any substance into Russia,” she said.

Griner said she still did not understand how the vape cartridges containing hashish oil could have ended up in her luggage.

“If I had to speculate, if I had to guess on how they ended up in my bags, I was in a rush packing,” she said. “I was recovering from COVID, the stress of packing, making sure I had my COVID tests. Jet lag.”

Griner said she had been prescribed medical cannabis in the United States to treat chronic injuries in the offseason, a treatment not uncommon among elite athletes in countries where the substance is allowed. It is, however, illegal in Russia.

“The benefits from medical cannabis definitely outweigh the painkillers that they prescribe,” said Griner, who has suffered a serious knee injury, broken her ankle and sustained several other injuries linked to her basketball career.

The case against her has highlighted strained relations between Russia and the United States that have plunged to a new post-Cold War low over the Russian military intervention in Ukraine.

U.S. officials and prominent athletes say Griner has been wrongly detained and have called for her immediate release, saying she is being used as a political pawn to secure the release of a Russian detained in the United States or other concessions from Washington.

The Kremlin has said the case has nothing to do with politics and that she should be tried for violating Russian laws. The next hearing is set for Aug. 2.

(Reporting by Reuters; Editing by Mark Trevelyan)

About the Author

Reuterscontributor

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products:

Did you find this article useful?

Advertisement